Tune in to listen as PwC’s leaders Roel van den Akker and Nick Donkar provide insights into the deals landscape 2023 and offer a preview of what lies ahead. Topics include:

• A look back at M&A activity in health industries so far in 2023
• The future of deals: The role of regulators, shareholders, and private equity in the health space
• Three areas to keep an eye on: potential legislative or tax changes, stabilization of debt markets and interest rates, and strong data sets

Speakers:
Roel van den Akker, Pharmaceutical and Life Sciences Deals Leader, PwC
Nick Donkar, Health Services Deals Leader, PwC
Igor Belokrinitsky, Strategy& Principal, PwC

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.